2.80Open4.12Pre Close6 Volume50 Open Interest74.00Strike Price1.68KTurnover46.81%IV0.51%PremiumDec 20, 2024Expiry Date2.41Intrinsic Value100Multiplier4DDays to Expiry0.39Extrinsic Value100Contract SizeAmericanOptions Type0.7551Delta0.0843Gamma25.47Leverage Ratio-0.1598Theta0.0059Rho19.23Eff Leverage0.0250Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet